Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs

Kathy Lee; Trupti Jani; Roger Cheng; Jordan Hunt

doi:10.12927/hcq.2020.26145

Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs

Healthc Q. 2020 Apr;23(1):10-12. doi: 10.12927/hcq.2020.26145.

Authors

Kathy Lee¹, Trupti Jani², Roger Cheng³, Jordan Hunt⁴

Affiliations

¹ A program lead in the Pharmaceuticals Department at the CIHI in Ottawa, Ontario. She leads and coordinates the analysis and writing of pharmaceutical-related reports at CIHI. Kathy can be reached at klee@cihi.ca.
² A senior analyst in the Pharmaceuticals Department at the CIHI in Ottawa, Ontario. She assisted with the analysis and writing of the Drug Spending in Canada reports at CIHI. Trupti can be reached at tjani@cihi.ca.
³ A senior analyst in the Pharmaceuticals Department at the CIHI in Ottawa, Ontario. He assisted with the analysis and writing of the Drug Spending in Canada reports at CIHI. Roger can be reached at rcheng@cihi.ca.
⁴ The manager of the Pharmaceuticals Department at the CIHI in Ottawa, Ontario. He oversees the development of pharmaceutical databases and pharmaceutical-related reports at CIHI. Jordan can be reached at jhunt@cihi.ca.

PMID: 32249733
DOI: 10.12927/hcq.2020.26145

Abstract

Public drug program spending accounts for 43.1% of prescribed drug spending in Canada. This report provides an in-depth look at public drug program spending in Canada, using the Canadian Institute for Health Information's (CIHI) National Prescription Drug Utilization Information System. Public drug program spending does not include spending on drugs dispensed in hospitals or on those funded through cancer agencies and other special programs.

MeSH terms

Canada
Drug Costs / statistics & numerical data*
Financing, Government / statistics & numerical data*
Financing, Government / trends
Health Expenditures / statistics & numerical data
Humans
Prescription Drugs / classification
Prescription Drugs / economics*

Substances

Prescription Drugs